Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupAnne W.M. Lee, Joseph T. F. Lau, Brian O’Sullivan et al.|Journal of Clinical Oncology|2005Cited by 448
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu‐Pei Chen, Nofisat Ismaila, Melvin L.K. Chua et al.|Journal of Clinical Oncology|2021Cited by 393
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinomaAnne W.M. Lee, Joseph Wee, Wai Tong Ng et al.|Radiotherapy and Oncology|2017Cited by 374
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal CarcinomaAnne W.M. Lee, Joseph Wee, Wai Tong Ng et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 183
Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumorYanan Tan, Xin‐Yuan Guan, Yongpeng Li et al.|Cancer Letters|2021Cited by 29